FibroBiologics Share Price

FibroBiologics Share Price

NASDAQ: FBLG | Healthcare
$0.71
-$0.12 (-14.32%) Last updated on 21 Nov, 2026 | 02:24 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

FibroBiologics Stock Performance

Open
$0.71
Prev. Close
$0.83
Circuit Range
N/A
Day Range
$0.71 - $0.71
Year Range
$0.19 - $2.82
Volume
200
Average Traded
$0.71

FibroBiologics Share Price Today

As of 22 November 2026, FibroBiologics, Inc.'s share price is $0.71. The stock opened at $0.71, compared to its previous close of $0.83. During today's trading session, FibroBiologics, Inc.'s share price traded between $0.71 and $0.71, with an average price of $0.71. Over the past 52 weeks, the stock has recorded a high of $2.82 and a low of $0.19. In terms of performance, FibroBiologics, Inc.'s share price has declined by 36.73% over the last six months and is up 162.87% on a year-on-year basis.

FibroBiologics Share Price Chart

Line chart of the FibroBiologics price trend over the selected period. The price fell overall, ranging from 0.71 to 0.71, ending at 0.71.
$0.71$0.71
L
Show Current Price
H

FibroBiologics Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.83
Revenue (TTM)
$0.00
Return On Equity (TTM)
-907.08%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-25.00%

FibroBiologics Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$3.24-$5.00-$4.12-$4.05
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-54.32%17.60%1.70%

FibroBiologics Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$0.00
Net Profit-$11.16-$18.65
Net Profit MarginN/AN/A
Income ChangeN/A-67.11%

FibroBiologics Balance Sheet

All figures in USD Million

Particulars20252024
Non Current Assets3.272.22
Current Assets6.3514.23
Total Assets9.6216.45
Non Current Liabilities1.70.98
Current Liabilities1.7612.73
Total Liabilities3.4613.71
Shareholders' Equity6.162.74

FibroBiologics Cash Flow

Annually

All figures in USD Million

Particulars20252024
Operating-16.39-11.9
Investing-0.26-0.18
Financing7.5716.91

Corporate Actions

Split
Ex-date: 30 Mar 2026

About FibroBiologics

FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications including thymic involution reversal using a thymic organoid. Its product candidates are CYWC628, CYPS317, CYMS101 and CybroCell.

FibroBiologics Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.95
$0.71
-26.29%
Oct 2026
$1.23
$0.97
-25.38%
Sep 2026
$1.78
$1.30
-7.47%
Aug 2026
$0.80
$1.41
+100.71%
Jul 2026
$0.93
$0.70
-24.89%
Jun 2026
$1.12
$0.93
-17.52%
May 2026
$1.35
$1.13
-15.67%
Apr 2026
$1.10
$1.34
+2.29%
Mar 2026
$0.33
$1.31
+306.83%
Feb 2026
$0.32
$0.32
-3.01%
Jan 2026
$0.22
$0.33
+49.55%
Dec 2025
$0.28
$0.22
-18.38%

FibroBiologics Share Price FAQs